ESR1 and breast cancer: To confirm activation of MYC gene in antiestrogen resistant cells, promoter luciferase activity was measured under basal conditions in ER + breast cancer cells that are either sensitive to antiestrogens (LCC1) or resistant to antiestrogens (LCC2, LY2 and LCC9).